EPISODE · Aug 19, 2026 · 33 MIN
Dupilumab in Children: A Game-Changer for Eczema, Asthma and Atopic Disease
from Hope & Histamine: The Paediatric Allergy Podcast · host Goodlife Creations
Dupilumab has transformed the treatment of several type 2 inflammatory conditions—but how does it work, which children may benefit, and what should clinicians and families know before starting treatment?In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the expanding role of dupilumab in paediatrics, including its use in atopic dermatitis (eczema), severe asthma and eosinophilic oesophagitis. We discuss how blocking interleukin-4 and interleukin-13 signalling helps control allergic inflammation, along with patient selection, administration, monitoring, potential adverse effects, and the practical considerations of biologic treatment.Whether you are a paediatrician, allergy specialist, healthcare professional, or parent, this episode provides a clear, clinically relevant introduction to how dupilumab is reshaping the management of childhood atopic disease.Sources:Foti Randazzese, S., Calamita, A., D’Angelo, D., Marseglia, A., Mesa Lombardero, E., Pedersoli, S., Tedeschi, M., De Amici, M., Manti, S., Brazzelli, V., Licari, A. and Marseglia, G.L. (2026) 'Emerging Paediatric Uses of Dupilumab Beyond Approvals', Clinical & Experimental Allergy. Available at: https://doi.org/10.1111/cea.70381.Gutsche, A., Grabowska, W., Altrichter, S., Grekowitz, E., Roll, S., Heine, G., Staubach, P., Pfützner, W., Brehler, R., Bauer, A., Wagner, N., Wurpts, G., Salameh, P., Salehzadeh-Yazdi, A., Jahandideh, S.S. and Metz, M. (2026) 'Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study', Allergy. Available at: https://doi.org/10.1111/all.70454.Lasek, A., Bellon, N., Mallet, S., Aubert, H., Vera, C., Achour, L., Thénié, C., Prescilla, R., Abasq-Thomas, C. and Barbarot, S. (2026) 'Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis', Journal of the European Academy of Dermatology and Venereology, 40, pp. 1208–1217. Available at: https://doi.org/10.1111/jdv.70268.Wechsler, M.E., Wenzel, S.E., Groshong, S.D., Castro, M., Pavord, I.D., Rabe, K.F., Laws, E., Jagerschmidt, A., Gayvert, K., Harel, S., Hamilton, J.D., Amin, N., Zhang, L., Xing, H., Elfakir, A., Coulibaly, B., Naimi, S., Hamon, S., Rowe, P.J., Nestle, F., Cunoosamy, D.M., de Rinaldis, E. and Mannent, L.P. (2026) 'Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma', Allergy. Available at: https://doi.org/10.1111/all.70391.🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTubeDisclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.Buy me a coffee: https://coff.ee/goodlifecreationsSend us Fan MailSupport the showBrought to you by - Goodlife Creations (2026). Music by - Denys Kyshchuk from Pixabay.
Embed this episode
What this episode covers
Dupilumab has transformed the treatment of several type 2 inflammatory conditions—but how does it work, which children may benefit, and what should clinicians and families know before starting treatment? In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the expanding role of dupilumab in paediatrics, including its use in atopic dermatitis (eczema), severe asthma and eosinophilic oesophagitis. We discuss how blocking interleukin-4 and interleukin-13 signalling...
Ready to play
Dupilumab in Children: A Game-Changer for Eczema, Asthma and Atopic Disease
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.